Close Menu

The ability to detect low levels of circulating tumor DNA (ctDNA) can be significantly improved by first analyzing mutations identified through tumor genotyping, according to a new study in Science Translational Medicine. While ctDNA has proven useful for noninvasive cancer monitoring, detecting this genetic material in patients with low-volume or residual disease remains challenging.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.